Janux Therapeutics Inc (JANX) Unusual Options Activity Today

Checking JANX unusual options activity helps you spot when traders are making outsized bets on Janux Therapeutics Inc before the broader market catches on. Janux Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor JANX unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching JANX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking JANX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and JANX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells.

In addition, its EGFR-TRACTr is designed to target EGFR in many cancer types with multiple approved monoclonal antibodies. The company was incorporated in 2017 and is headquartered in La Jolla, California.

Catalysts rarely arrive without a footprint, and JANX unusual options activity is often where that footprint shows up first. Our scanner tracks Janux Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at JANX unusual options volume on the call side or chasing put sweeps, Janux Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.